Skip to the page

Data / Form D filings / Aspicio Therapeutics, Inc.

Aspicio Therapeutics, Inc.: Form D filings

Aspicio Therapeutics, Inc., a health care company in Downingtown, PA, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on July 17, 2026, reports $200,000 sold of a $200,000 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
250 TRUMAN WAY, Downingtown, PA, 19335
Phone
(484) 885-4744
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2025735

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 17, 2026New notice$200,000$200,0002Jul 16, 2026sec.gov
Jun 21, 2024New notice$400,000$400,0003Jun 18, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael KeaneExecutive Officer, Director

Other health care companies in Pennsylvania that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in Pennsylvania · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Aspicio Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.